{"SPADE_UN_17444": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17444", "Peptide Name": "Aurein-2.2 (1-14)[V10L, G11R, A12L, G14K]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GLFDIVKKVLRLLK", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/P82389"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C79H140N20O17", "Mass": 1642.08, "PI": 10.29, "Net Charge": 3, "Hydrophobicity": 0.77, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Simulated Molecular Evolution for Anticancer Peptide Design", "Pubmed ID": "30506920", "Reference": "Angew Chem Int Ed Engl. 2019 Feb 4;58(6)1674-1679.", "Author": "Neuhaus CS, Gabernet G, Steuer C, Root K, Hiss JA, Zenobi R, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30506920"}], "Frequent Amino Acids": "LKV", "Absent Amino Acids": "ACEHMNOPQSTUWY", "Basic Residues": 4, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 4, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11592", "Similarity": 1.0, "Sequence": "KKKKPLFGLFFGLF"}, {"SPADE_ID": "SPADE_UN_21832", "Similarity": 1.0, "Sequence": "LRLLKRRWKYRVPP"}, {"SPADE_ID": "SPADE_UN_03981", "Similarity": 1.0, "Sequence": "RLLKRFKHLFK"}]}}}